30233U2Transfusion of Allogeneic Related T-cell Depleted Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach
- Billable / Specific Code
30233U2 is a billable ICD-10-PCS procedure code for Transfusion of Allogeneic Related T-cell Depleted Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 014. The root operation Transfusion involves putting in blood or blood products. In AHRQ's Clinical Classifications Software (CCSR), this procedure falls under Administration and transfusion of bone marrow, stem cells, pancreatic islet cells, and t-cells.
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | 3 | Administration |
| 2 | Body System | 0 | Circulatory |
| 3 | Operation | 2 | Transfusion |
| 4 | BodySystem/Region | 3 | Peripheral Vein |
| 5 | Approach | 3 | Percutaneous |
| 6 | Substance | U | Stem Cells, T-cell Depleted Hematopoietic |
| 7 | Qualifier | 2 | Allogeneic, Related |
Clinical Classification (CCSR)
AHRQ groups 30233U2 into these clinical categories.
Code History
- 30233Y2 — Transfuse Allo Rel Hemat Stem Cell in Periph Vein, Perc
Similar Procedure Codes
Questions About 30233U2
Is 30233U2 a billable code?
Yes. 30233U2 is a complete seven-character ICD-10-PCS code, specific enough to report Transfusion of Allogeneic Related T-cell Depleted Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach on inpatient claims from October 1, 2025 through September 30, 2026.
What do the characters in 30233U2 mean?
30233U2 breaks down character by character: the 1st character 3 is the Section (Administration); the 2nd character 0 is the Body System (Circulatory); the 3rd character 2 is the Operation (Transfusion); the 4th character 3 is the BodySystem/Region (Peripheral Vein); the 5th character 3 is the Approach (Percutaneous); the 6th character U is the Substance (Stem Cells, T-cell Depleted Hematopoietic); the 7th character 2 is the Qualifier (Allogeneic, Related).
What MS-DRG does 30233U2 group to?
On an inpatient stay, Transfusion of Allogeneic Related T-cell Depleted Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach maps to MS-DRG 014 (allogeneic Bone Marrow Transplant). The MS-DRG sets the fixed Medicare payment for the stay.